Skip to main content
Premium Trial:

Request an Annual Quote

Strata Develops Gene Validation Technology

Premium

ALAMEDA, Calif.--Strata Biosciences, a privately funded genomics company here, said it has developed proprietary tools with the capacity to knock out 100 genes per month using multiple vector systems, in an effort to attach functional relevance to gene sequences, discover disease-relevant genes, validate targets, and determine gene members of biological pathways.

Douglas Lane, Strata's president and CEO, remarked, "The pharmaceutical industry has invested more than $3.8 billion in gene discovery to find targets for drugs, but with the 135,000 presumed discovered genes, all but a few hundred have no known, confirmed functional relevance in disease."

Lane said his company is working to discover thousands of targets within the next three years by analyzing hundreds of thousands of genes implicated in each investigated disease process.

He added that Strata will "initially focus on major killers, including prostate and ovarian cancer, and a better understanding of immune regulation."

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.